(1S)-11-Bromo-1α-[(tert-butoxycarbonyl)amino]-1,2,7,8,13,13bβ-hexahydro[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indole 3-oxide structure
|
Common Name | (1S)-11-Bromo-1α-[(tert-butoxycarbonyl)amino]-1,2,7,8,13,13bβ-hexahydro[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indole 3-oxide | ||
---|---|---|---|---|
CAS Number | 115276-14-7 | Molecular Weight | 470.381 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C19H24BrN3O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | 2-Methyl-2-propanyl [(1S,13bS)-11-bromo-3-oxido-1,2,7,8,13,13b-hexahydro[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol-1-yl]carbamate |
---|---|
Synonym | More Synonyms |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C19H24BrN3O4S |
Molecular Weight | 470.381 |
Exact Mass | 469.067078 |
LogP | 1.62 |
Index of Refraction | 1.696 |
2-Methyl-2-propanyl [(1S,13bS)-11-bromo-3-oxido-1,2,7,8,13,13b-hexahydro[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol-1-yl]carbamate |
Carbamic acid, N-[(1S,13bS)-11-bromo-1,2,7,8,13,13b-hexahydro-3-oxido[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol-1-yl]-, 1,1-dimethylethyl ester |